Gene mutations within the PI3K/Akt/mTOR pathway are identified in numerous types of malignancies, among others, lung cancer, brain cancer, colorectal cancer, ovarian cancer, breast cancer and uterus cancer [3,8,9,10,11,12,13,14,15]. This evidence concerns the gene MTOR and breast carcinoma.